Related Experiment Video
Updated: Aug 15, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
[Clinics in prostate cancer]
1Department of Urology, Mie University School of Medicine, Tsu 514-8507.
Abstract:
The prostate gland is characterized by the age-dependent development of abnormal proliferative disease, i.e., benign prostate hyperplasia and prostate cancer. Prostate cancer is the most important disease in our country among the elderly population. The diagnosis and treatment of prostate cancer have been dramatically improved due to the development of PSA screening, transrectal ultrasonography and new anti-androgen drugs, such as LH-RH analog, with fewer side effects. In this article, the pathogenesis, diagnosis and treatment of prostate cancer are summarized.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

